Nina Capital

Quantivly, Inc., established in 2019 and headquartered in Somerville, Massachusetts, specializes in developing artificial intelligence-based solutions tailored for the field of radiology. The company focuses on enhancing data liquidity and providing analytical tools that enable radiology providers to make informed decisions, thereby increasing access to medical imaging services. Quantivly's platform is designed to manage and analyze MRI imaging workflows by cleaning and harmonizing scanner data, resulting in a vendor-neutral and comprehensive source of operational knowledge. This innovative approach supports radiology departments and imaging centers in utilizing data analytics to improve decision-making, facilitate new research initiatives, and enhance the overall patient experience in healthcare.

CryoCloud is a biotechnology company specializing in cloud-based image analysis solutions. Its primary focus is accelerating protein structure determination through a cloud-native platform for cryo-electron microscopy (cryo-EM) data analysis.

Magentiq Eye Ltd., established in 2014, specializes in developing AI-driven medical devices for endoscopic procedures. Its flagship product is the Automatic Polyp Detection System (APDS), which uses computer vision and deep learning to assist doctors in real-time colonoscopy examinations, aiming to reduce polyp miss-rates and improve patient outcomes.

Quantivly, Inc., established in 2019 and headquartered in Somerville, Massachusetts, specializes in developing artificial intelligence-based solutions tailored for the field of radiology. The company focuses on enhancing data liquidity and providing analytical tools that enable radiology providers to make informed decisions, thereby increasing access to medical imaging services. Quantivly's platform is designed to manage and analyze MRI imaging workflows by cleaning and harmonizing scanner data, resulting in a vendor-neutral and comprehensive source of operational knowledge. This innovative approach supports radiology departments and imaging centers in utilizing data analytics to improve decision-making, facilitate new research initiatives, and enhance the overall patient experience in healthcare.

EarlySight, a Lausanne-based medical device company, develops technology to detect and treat eye diseases at an early stage. Its flagship work includes a fundus camera that images the retina with high detail by combining eye illumination with real time ocular aberration correction. The company also leverages cellular level imaging and transscleral illumination to monitor day to day treatment effects in a non invasive manner, enabling eye specialists to visualize the morphology of retinal cells. Founded in 2016, EarlySight aims to bring its imaging technology to clinics to improve early diagnosis and treatment of ocular conditions.

contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.

PlenOptika, Inc. is a technology company based in Allston, Massachusetts, that specializes in the development of a handheld device called QuickSee, which provides accurate eyeglass prescriptions through precise refractive measurements. Founded in 2014 as a spin-off from the Massachusetts Institute of Technology, the company addresses the significant global issue of low vision affecting over one billion people. QuickSee is designed to facilitate optometry, especially in rural and resource-limited settings, by simplifying the process of vision correction. The device captures the eye's full aberration fingerprint, effectively reducing the costs and physical space required by traditional autorefractors. PlenOptika aims to make eye care accessible to underserved communities worldwide and has received recognition from various social innovation foundations and business competitions for its contributions to healthcare technology.

Subtle Medical is a healthcare technology company that develops artificial‑intelligence software for magnetic resonance and positron emission tomography imaging. Its flagship products, SubtleMR and SubtlePET, are FDA‑cleared and CE‑marked tools that enhance image quality by reducing noise and sharpening detail, allowing scans to be performed faster and with lower radiation or contrast dose. The company’s deep‑learning algorithms integrate with any scanner without changing existing workflows, enabling imaging centers and hospitals to increase throughput and improve patient safety. Subtle Medical also offers a vendor‑agnostic AI platform that delivers analytics and support to clinical imaging providers. Founded in 2017 and headquartered in Menlo Park, California, the firm has received an NIH SBIR grant and an RSNA award for its GAD technology.

EarlySight, a Lausanne-based medical device company, develops technology to detect and treat eye diseases at an early stage. Its flagship work includes a fundus camera that images the retina with high detail by combining eye illumination with real time ocular aberration correction. The company also leverages cellular level imaging and transscleral illumination to monitor day to day treatment effects in a non invasive manner, enabling eye specialists to visualize the morphology of retinal cells. Founded in 2016, EarlySight aims to bring its imaging technology to clinics to improve early diagnosis and treatment of ocular conditions.

contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.

PlenOptika, Inc. is a technology company based in Allston, Massachusetts, that specializes in the development of a handheld device called QuickSee, which provides accurate eyeglass prescriptions through precise refractive measurements. Founded in 2014 as a spin-off from the Massachusetts Institute of Technology, the company addresses the significant global issue of low vision affecting over one billion people. QuickSee is designed to facilitate optometry, especially in rural and resource-limited settings, by simplifying the process of vision correction. The device captures the eye's full aberration fingerprint, effectively reducing the costs and physical space required by traditional autorefractors. PlenOptika aims to make eye care accessible to underserved communities worldwide and has received recognition from various social innovation foundations and business competitions for its contributions to healthcare technology.

contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.

MindPeak GmbH is a technology company based in Hamburg, Germany, founded in 2018. It specializes in developing artificial intelligence software tools aimed at enhancing the accuracy and efficiency of cancer diagnostics. The company's flagship product, BreastAI, is designed for the quantification of breast cancer immunohistochemistry (IHC) and can be integrated into third-party software systems. MindPeak's solutions automate tissue diagnostics, enabling pathologists to identify and quantify tumorous regions and detect breast cancer cells more effectively. By streamlining tasks such as cell and biomarker quantification, MindPeak's tools allow cancer specialists to focus on critical decision-making in clinical environments, ultimately improving patient care while making diagnostic processes more accessible and cost-effective.

Kheiron Medical Technologies is a London-based medical technology company that develops Mia, an AI-powered mammography screening tool designed to help radiologists detect breast cancer. The system combines deep learning with radiology insights to improve detection efficiency, consistency, and accuracy across imaging workflows. Incorporated in 2016 and formerly known as Maesterai, the company maintains an international presence with offices in London, San Francisco, Budapest, and Amsterdam, aiming to advance precision radiology and improve outcomes for cancer patients.

CryoCloud is a biotechnology company specializing in cloud-based image analysis solutions. Its primary focus is accelerating protein structure determination through a cloud-native platform for cryo-electron microscopy (cryo-EM) data analysis.